Preferential generation of human T cell hybrids with a tetraploid fusion partner.
The factors determining successful derivation of human T lymphocyte hybrids are largely unknown. This report describes diploid and tetraploid clones of the T cell line CEM which were fused with either a human T cell line (Jurkat) or with peripheral blood lymphocytes (PBL). Fusions of all CEMR clones with the Jurkat cell line yielded hybrids at a very high frequency (1 X 10(-4)). Fusion of diploid clones of CEM with PBL yielded no hybrids, whereas fusion of tetraploid clones of CEM with PBL resulted in growth frequencies of 1 to 3 X 10(-6). Enumeration of hybrids immediately after fusion indicated that in all cases, fused cells represented 5 to 10% of the population. That the ability to yield viable hybrids after fusion was a characteristic of tetraploid cells was indicated by the finding that tetraploid variants of a diploid clone could also yield viable hybrids after fusion. Possible mechanisms for the difference in results generated with diploid and tetraploid cells, and characteristics of the hybrid cells generated, are also discussed.
D000954:Antigens, Surface / Q000032:analysis; D002455:Cell Division; D002459:Cell Fusion; D002460:Cell Line; D006801:Humans; D006825:Hybridomas / Q000166:cytology*; D007621:Karyotyping; D011123:Polyploidy; D013601:T-Lymphocytes / Q000166:cytology*
D000954:Antigens, Surface